Concord, CA, United States of America

Asaad S Nematalla

This inventor holds 15 USPTO granted patents. Top assignees: Sugen Incorporated, Agouron Pharmaceuticals, Inc., Pharmacia & Upjohn Company. Active years: 1998-2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Asaad S Nematalla. Retrieved from https://idiyas.com/inventor/asaad-s-nematalla

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 73.3

Average Co-Inventor Count = 5.2

ph-index = 10

Forward Citations = 311(Granted Patents)


Location History:

  • Lafayette, CA (US) (2000)
  • Walnut Creek, CA (US) (1998 - 2005)
  • Orinda, CA (US) (2004 - 2006)
  • Concord, CA (US) (2003 - 2009)

Company Filing History:


Years Active: 1998-2009

Loading Chart...
15 patents (USPTO):Explore Patents

Title: Inventor Spotlight - Asaad S Nematalla

Introduction: Asaad S Nematalla is a prolific inventor based in Concord, California, known for his groundbreaking contributions to various fields.

Latest Patents: Asaad S Nematalla holds several patents in the areas of technology and engineering, showcasing his innovative mindset and problem-solving abilities.

Career Highlights: Throughout his career, Asaad S Nematalla has demonstrated a keen interest in pushing the boundaries of traditional thinking, leading to the development of cutting-edge solutions that have made a significant impact.

Collaborations: Asaad S Nematalla has collaborated with top industry experts and research institutions to further his inventions, highlighting his commitment to excellence and collaboration in the innovation space.

Conclusion: Asaad S Nematalla's dedication to innovation and his remarkable contributions to the field make him a standout inventor in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…